Home > Boards > US Listed > Medical - Drugs > Arbutus Biopharma Corporation (ABUS)

Doctor coming to U.S. for treatment

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
JRT Member Profile
Member Level 
Followed By 76
Posts 6,997
Boards Moderated 0
Alias Born 06/22/11
160x600 placeholder
Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright BioConnect 2021 Conference GlobeNewswire Inc. - 1/4/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/16/2020 4:34:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/10/2020 7:33:06 AM
Arbutus Announces Robust HBsAg Decline Data with AB-729 Dosed at 60 mg Every 8 Weeks in Chronic Hepatitis B Subjects GlobeNewswire Inc. - 12/10/2020 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 8:01:24 AM
Arbutus Announces Additional Robust HBsAg Decline Data with AB-729 in Chronic Hepatitis B Subjects GlobeNewswire Inc. - 11/16/2020 7:00:00 AM
Arbutus Announces Presentation of Phase 1a/1b Clinical Trial Results for AB-729 in Chronic Hepatitis B Subjects at The Liver ... GlobeNewswire Inc. - 11/15/2020 2:39:41 PM
Arbutus to Present at Jefferies Virtual London Healthcare Conference GlobeNewswire Inc. - 11/10/2020 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 4:12:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 8:31:20 AM
Arbutus Reports Third Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 11/5/2020 7:30:00 AM
Arbutus to Report Third Quarter 2020 Financial Results and Provide Corporate Update GlobeNewswire Inc. - 10/29/2020 8:00:10 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/23/2020 6:04:20 AM
Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright Hepatitis B Virus (HBV) Mini-Conference GlobeNewswire Inc. - 10/13/2020 8:00:10 AM
Arbutus to Participate in Virtual Fireside Chat at Chardan’s 4th Annual Genetic Medicines Conference GlobeNewswire Inc. - 9/28/2020 8:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/25/2020 4:07:28 PM
Arbutus Announces AB-729 90 mg Single-Dose Week 12 Data in Chronic Hepatitis B Subjects Demonstrating Significant and Continu... GlobeNewswire Inc. - 9/15/2020 7:30:10 AM
Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2020 8:00:10 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 9/1/2020 4:43:27 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/28/2020 4:07:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2020 8:18:17 AM
Assembly Biosciences and Arbutus Biopharma Announce Clinical Collaboration Agreement to Evaluate the Combination of Core Inhi... GlobeNewswire Inc. - 8/27/2020 8:00:10 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/7/2020 4:55:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/7/2020 4:48:55 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2020 4:25:41 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences